Provided by Tiger Fintech (Singapore) Pte. Ltd.

XORTX Therapeutics Inc.

0.9480
+0.08609.98%
Volume:9.97K
Turnover:8.71K
Market Cap:3.59M
PE:-0.82
High:0.9480
Open:0.8620
Low:0.8620
Close:0.8620
Loading ...
Nov 22, 2024

Correspondence

Form CORRESP - Correspondence
Nov 15, 2024

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
May 10, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Apr 28, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2023

Correspondence

CORRESP [Cover] - Correspondence
Jan 27, 2023

[Rev.]Annual Report

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Oct 28, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Sep 22, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 22, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 21, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 21, 2022

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Sep 19, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 19, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 14, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 12, 2022

[Amend]Public Prospectus

F-1/A [Amend] - Registration statement for certain foreign private issuers
Sep 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 08, 2022

Correspondence

CORRESP [Cover] - Correspondence
Sep 08, 2022

Public Prospectus

F-1 - Registration statement for certain foreign private issuers